Sumitomo Mitsui Trust Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Sell |
1,594,518
-1,331,505
| -46% | -$3.29M | ﹤0.01% | 736 |
|
|
2025
Q1 | $5.82M | Sell |
2,926,023
-164,157
| -5% | -$327K | ﹤0.01% | 723 |
|
|
2024
Q4 | $9.02M | Sell |
3,090,180
-100,275
| -3% | -$293K | 0.01% | 713 |
|
|
2024
Q3 | $12.3M | Sell |
3,190,455
-47,930
| -1% | -$185K | 0.01% | 693 |
|
|
2024
Q2 | $16.6M | Sell |
3,238,385
-126,278
| -4% | -$649K | 0.01% | 663 |
|
|
2024
Q1 | $23.6M | Sell |
3,364,663
-154,366
| -4% | -$1.08M | 0.02% | 682 |
|
|
2023
Q4 | $31.2M | Sell |
3,519,029
-115,819
| -3% | -$1.03M | 0.02% | 611 |
|
|
2023
Q3 | $34.7M | Buy |
3,634,848
+571,097
| +19% | +$5.45M | 0.03% | 564 |
|
|
2023
Q2 | $44.9M | Buy |
3,063,751
+2,066,179
| +207% | +$30.3M | 0.04% | 503 |
|
|
2023
Q1 | $12.3M | Buy |
997,572
+509,346
| +104% | +$6.26M | 0.01% | 773 |
|
|
2022
Q4 | $9.07M | Buy |
+488,226
| New | +$9.07M | 0.01% | 793 |
|